Promis Neurosciences Inc

Ordinary Shares International Reporting
Verified Company Profile 12/04/2017
Contact Info
  • 1920 Yonge Street
  • Suite 200
  • Toronto, ONT M4S 3E2
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: Toronto Stock Exchange
Audited Financials Audited
Latest Report Sep 30, 2017 Quarterly Report
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: Canada
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Elliot Goldstein CEO, President
Steven Plotkin Officer
Daniel E. Geffken CFO
Johanne Kaplan Chief Development Officer
Neil Cashman Chief Scientific Officer
Kristi Lanier Director, Fin.
Company Directors
Eugene Williams Executive Chairman
Anthony J Giovinazzo
Richard Gregory
Patrick Kirwin
Johannes Minho Roth
William Wyman
Company Notes
  • Formerly=Amorfix Life Sciences Ltd. until 7-2015
Service Providers
Accounting/Auditing Firm
PricewaterhouseCoopers LLP
PwC Tower
18 York Street, Suite 2600
Toronto, ONT, M5J 0B2

Legal Counsel
McMillan LLP
Royal Centre, 1500-1055 West Georgia Street
PO Box 11117
Vancouver, BC, V6E 4N7

Investor Relations Firm
Russo Partners LLC
75 Ninth Avenue
New York, NY, 10011
United States

Alpine Equity Advisors
41 Commonwealth Avenue
Boston, MA, 02116
United States

ARFXF Security Details
Share Structure
Market Value1 $82,786,020 a/o Jan 23, 2018
Authorized Shares Unlimited a/o Nov 08, 2017
Outstanding Shares 220,058,534 a/o Nov 08, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s) Verified by Transfer Agent
Shareholders of Record Not Available
Non US Stock Exchange Listing
PMN - Toronto Stock Exchange - Qualified
Short Selling Data
Short Interest 1,838 (100%)
Dec 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security